# Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy and Distal Pancreatic Resection

> **NCT01460615** · PHASE2 · COMPLETED · sponsor: **Tampere University Hospital**

## Conditions studied

- Postoperative Complications
- Postoperative Pancreatitis

## Interventions

- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT01460615
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** — (—)
- **Last updated:** 2018-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01460615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01460615, "Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy and Distal Pancreatic Resection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01460615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*